Sanofi enters into a dual partnership agreement with Alliance Healthcare and Phoenix

The groundbreaking collaboration is expected to improve service levels and stock availability of key products to UK pharmacies.

Opella Healthcare, trading as Sanofi Consumer Healthcare, recently signed a dual partnership agreement with Alliance Healthcare and Phoenix Healthcare Distribution for the wholesale supply of its consumer healthcare products to community pharmacies throughout the United Kingdom.

The new dual pharmacy wholesale partnership model, which became effective on 1 February 2024, underscores Sanofi’s commitment to delivering exceptional customer service to its customers, the company said in a press release.

The groundbreaking collaboration is expected to enhance operational efficiency as part of the company's go-to-market model, facilitating improved service levels and stock availability of key products, including Cialis® Together, Allevia®, Buscopan®, Dulcolax®, and Phenergan, to community pharmacies in the UK.

Nick Linton, head of UK country operations, Sanofi Consumer Healthcare, said that the company is committed to supporting the “self-care agenda” in the UK.

“Making healthcare as simple as it should be to bring health and wellbeing to all is a key priority for us in 2024 and beyond,” he commented.

Sanofi’s new wholesale model reflects its deep commitment to working as efficiently as possible in “close partnership with pharmacists” to shape a healthier future, he added.

An innovative global healthcare company, Sanofi maintains a widespread presence spanning 100 countries, providing potentially life-changing treatment options and potentially life-saving vaccine protection to millions of people globally.